<DOC>
	<DOC>NCT02692261</DOC>
	<brief_summary>Sinus augmentation is a predictable method when alveolar bone height is not sufficient for dental implant placement in posterior maxillary alveolar region..The aim of this prospective, randomized, controlled clinical study is comparison of hyaluronic acid originated matrix and equine derived xenograft with only xenograft use in sinus augmentation by micro computed tomography and histomorphometry.</brief_summary>
	<brief_title>Hyaluronic Matrix Efficacy for Maxillary Sinus Augmentation</brief_title>
	<detailed_description />
	<criteria>Systemically healthy patients Requiring bilateral maxillary sinus augmentation (residual crest height â‰¤ 4 mm) Advanced systemic diseases Chronic medication use Maxillary sinus disease Current pregnancy Lactation Smoking habit</criteria>
	<gender>All</gender>
	<minimum_age>33 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>